About

Travera helps oncologists make more informed treatment decisions through its revolutionary cancer therapy guidance platform. Using a proprietary single-cell measurement technology initially invented at MIT, Travera provides real-time, ex vivo insights into how a patient’s tumor or immune cells respond to different drugs. Travera’s portfolio includes the 2-day RapidSelection™ test and now the blood-based NOVA immune vitality assay—helping patients identify their best next option, faster.